HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
LINC00299 |
Q6ZSB3
|
long intergenic non-protein coding RNA 299
|
|
|
0.743 |
0.346 |
LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
SPRY4-AS1 |
|
SPRY4 antisense RNA 1
|
|
|
0.890 |
0.192 |
HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
LINC01150 |
|
long intergenic non-protein coding RNA 1150
|
|
|
0.931 |
0.038 |
DISC1FP1 |
|
DISC1 fusion partner 1
|
|
|
0.931 |
0.038 |
SLC2A1-AS1 |
|
SLC2A1 antisense RNA 1
|
|
|
1.000 |
|
TRAV30 |
A0A087WSZ9
|
T cell receptor alpha variable 30
|
|
|
0.861 |
0.038 |
LINC00298 |
|
long intergenic non-protein coding RNA 298
|
|
|
0.861 |
0.038 |
NBPF13P |
|
NBPF member 13, pseudogene
|
|
|
0.890 |
0.038 |
LINC02251 |
|
long intergenic non-protein coding RNA 2251
|
|
|
1.000 |
|
SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
LINC00836 |
|
long intergenic non-protein coding RNA 836
|
|
|
1.000 |
|
NTM-AS1 |
Q6ZSK4
|
NTM antisense RNA 1
|
|
|
1.000 |
|
LINC02748 |
|
long intergenic non-protein coding RNA 2748
|
|
|
1.000 |
|
LINC00937 |
|
long intergenic non-protein coding RNA 937
|
|
|
1.000 |
|